In CLL cells, extracellular IL6 or BCR signaling induces tyrosine phosphorylation of STAT3 [73, 74], leading to upregulated of anti-apoptosis genes and a survival advantage. This evidence concerns the gene IL6 and B-cell chronic lymphocytic leukemia.